UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Endothelial Progenitor Cells Bind and Inhibit Platelet Function and Thrombus Formation

Circulation (New York, N.Y.), 2009-12, Vol.120 (22), p.2230-2239

2009

Volltextzugriff (PDF)

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

Biological psychiatry (1969), 2007-08, Vol.62 (4), p.302-308

2007

Volltextzugriff (PDF)

Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets

PloS one, 2011-04, Vol.6 (4), p.e18812-e18812

2011

Volltextzugriff (PDF)

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

Circulation (New York, N.Y.), 1999-06, Vol.99 (25), p.3227-3233

1999

Volltextzugriff (PDF)

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Circulation (New York, N.Y.), 1999-11, Vol.100 (20), p.2045-2048

1999

Volltextzugriff (PDF)

Pathophysiology of coronary artery disease

Circulation (New York, N.Y.), 2005-06, Vol.111 (25), p.3481-3488

2005

Volltextzugriff (PDF)

Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment―Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies

Circulation (New York, N.Y.), 2009-06, Vol.119 (24), p.3101-3109

2009

Volltextzugriff (PDF)

Intracoronary thrombus and platelet glycoprotein IIb/IIIa receptor blockade with tirofiban in unstable angina or non-Q-wave myocardial infarction: Angiographic results from the PRISM-PLUS Trial (platelet receptor inhibition for ischemic syndrome management in patients limited by unstable signs and symptoms)

Circulation (New York, N.Y.), 1999-10, Vol.100 (15), p.1609-1615

1999

Volltextzugriff (PDF)

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

European heart journal. Acute cardiovascular care, 2014-03, Vol.3 (1), p.37-45

2014

Volltextzugriff (PDF)

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Circulation (New York, N.Y.), 2001-06, Vol.103 (25), p.3069-3074

2001

Volltextzugriff (PDF)

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

Circulation (New York, N.Y.), 1998-01, Vol.97 (3), p.251-256

1998

Volltextzugriff (PDF)

Clinical outcomes of bivalirudin for ischemic heart disease

Circulation (New York, N.Y.), 1999-11, Vol.100 (20), p.2049-2053

1999

Volltextzugriff (PDF)

Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non―ST-Segment Elevation Acute Coronary Syndromes: A Systematic Overview of Randomized Clinical Trials

Circulation Cardiovascular quality and outcomes, 2011-07, Vol.4 (4), p.448-458

2011

Volltextzugriff (PDF)

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

International journal of cardiology, 2013-07, Vol.167 (2), p.548-554

2013

Volltextzugriff (PDF)

The Association Between Major Depression and Levels of Soluble Intercellular Adhesion Molecule 1, Interleukin-6, and C-Reactive Protein in Patients With Recent Acute Coronary Syndromes

The American journal of psychiatry, 2004-02, Vol.161 (2), p.271-277

2004

Volltextzugriff (PDF)

Additive Effects of Obesity and TCF7L2 Variants on Risk for Type 2 Diabetes Among Cardiac Patients

Diabetes care, 2007-06, Vol.30 (6), p.1621-1623

2007

Volltextzugriff (PDF)

Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug

Journal of the American College of Cardiology, 2005-08, Vol.46 (4), p.638-645

2005

Volltextzugriff (PDF)

Previous aspirin use may attenuate the severity of the manifestation of acute Ischemic syndromes

Circulation (New York, N.Y.), 1995-10, Vol.92 (7), p.1743-1748

1995

Volltextzugriff (PDF)

Antithrombotic Agents in Coronary Artery Disease

Chest, 2001-01, Vol.119 (1), p.228S-252S

2001

Volltextzugriff (PDF)

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina : The Canadian lamifiban study

Circulation (New York, N.Y.), 1996-09, Vol.94 (5), p.899-905

1996

Volltextzugriff (PDF)

A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians

The American heart journal, 2001-08, Vol.142 (2), p.336-339

2001

Volltextzugriff (PDF)

Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinicl benefits of aspirin?

The American heart journal, 1997-11, Vol.134 (5), p.s62-s70

Théroux, Pierre

1997

Volltextzugriff (PDF)

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial

The Journal of thoracic and cardiovascular surgery, 2003-09, Vol.126 (3), p.807-813

2003

Volltextzugriff (PDF)

1 – 25 von 296

Suche als RSS-Feed

Aktive Filter

ThemaMyocardial Infarction - Drug Therapy

Nur zeigenMit Volltextzugriff

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(285)

Publikationsform

Sprache

Englisch
(296)
Japanisch
(34)

Erscheinungsjahr

n.n

Thema

Science & Technology
(170)
Life Sciences & Biomedicine
(167)
Humans
(166)
Cardiovascular System & Cardiology
(133)
Cardiac & Cardiovascular Systems
(132)
Biological And Medical Sciences
(110)
Medical Sciences
(110)
Male
(106)
Female
(101)
Middle Aged
(94)
Cardiology. Vascular System
(64)
Aged
(61)
Heart
(60)
Coronary Heart Disease
(54)
Electrocardiography
(48)
Adult
(46)
Pharmacology. Drug Treatments
(41)
Peripheral Vascular Disease
(34)
Blood. Blood Coagulation. Reticuloendothelial System
(30)
Myocardial Infarction - Therapy
(30)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Endothelial Progenitor Cells Bind and Inhibit Platelet Function and Thrombus Formation

Depression, C-reactive Protein and Two-year Major Adverse Cardiac Events in Men after Acute Coronary Syndromes

Requirements for membrane attack complex formation and anaphylatoxins binding to collagen-activated platelets

Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes: The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines

Platelet glycoprotein IIb/IIIa receptor inhibition in non-ST-elevation acute coronary syndromes: Early benefit during medical treatment only, with additional protection during percutaneous coronary intervention

Pathophysiology of coronary artery disease

Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment―Elevation Myocardial Infarction: Bayesian Hierarchical Meta-Analyses of Randomized Controlled Trials and Observational Studies

The Use of Antiplatelet Therapy in the Outpatient Setting: Canadian Cardiovascular Society Guidelines Executive Summary

Outcomes among non-ST-segment elevation acute coronary syndromes patients with no angiographically obstructive coronary artery disease: observations from 37,101 patients

Aspirin, warfarin, or the combination for secondary prevention of coronary events in patients with acute coronary syndromes and prior coronary artery bypass surgery

Platelet activation with unfractionated heparin at therapeutic concentrations and comparisons with a low-molecular-weight heparin and with a direct thrombin inhibitor

Clinical outcomes of bivalirudin for ischemic heart disease

Upstream Use of Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients With Non―ST-Segment Elevation Acute Coronary Syndromes: A Systematic Overview of Randomized Clinical Trials

Trends in clinical trials of non-ST-segment elevation acute coronary syndromes over 15 years

The Association Between Major Depression and Levels of Soluble Intercellular Adhesion Molecule 1, Interleukin-6, and C-Reactive Protein in Patients With Recent Acute Coronary Syndromes

Additive Effects of Obesity and TCF7L2 Variants on Risk for Type 2 Diabetes Among Cardiac Patients

Matching the Evaluation of the Clinical Efficacy of Clopidogrel to Platelet Function Tests Relevant to the Biological Properties of the Drug

Previous aspirin use may attenuate the severity of the manifestation of acute Ischemic syndromes

Antithrombotic Agents in Coronary Artery Disease

Platelet membrane receptor glycoprotein IIb/IIIa antagonism in unstable angina : The Canadian lamifiban study

A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians

Antiplatelet therapy: Do the new platelet inhibitors add significantly to the clinicl benefits of aspirin?

Prognostic significance of elevated creatine kinase MB after coronary bypass surgery and after an acute coronary syndrome: results from the GUARDIAN trial

Aktive Filter

Suchergebnisse filtern